ARN announces launch of ReSTART online recovery source for rehabilitation The Association of Rehabilitation Nurses today announced the release of the brand-new ReSTART online recovery resource for rehabilitation more . The ReSTART site provides important information for all those starting the journey of rehabilitation, as well as their family members, family members, and caretakers. The recovery site was created by rehabilitation nurses who understand the unique needs of people who experience a major injury, chronic illness, or disability. Using the ReSTART site, guests can learn about what to expect when first beginning rehabilitation, steps to make the most of taking part in the rehabilitation trip, how to greatest manage transitions between facilities and healthcare settings, and common monetary and legal concerns, such as insurance plan and disability qualification questions.
In the first one fourth of 2013. Also, the Marketing Authorization Program for ponatinib, submitted in August, has been validated by the European Medications Agency , commencing their overview of the application. The Committee for Medicinal Products for Human Use has granted ARIAD’s obtain accelerated evaluation of the MAA.. ARIAD Pharmaceuticals completes rolling submission of ponatinib NDA with FDA ARIAD Pharmaceuticals, Inc. today announced it has completed the rolling submission of the New Drug Program for its investigational BCR-ABL inhibitor, ponatinib, to the U.S.